Guardant Health
GH
#1519
Rank
A$21.27 B
Marketcap
A$163.83
Share price
0.75%
Change (1 day)
178.11%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): A-$5.02

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is A-$4.80. In 2024 the company made an earnings per share (EPS) of A-$5.32 an increase over its 2023 EPS that were of A-$6.40.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$5.02-5.77%
2024A-$5.32-16.82%
2023A-$6.40-33.13%
2022A-$9.5760%
2021A-$5.9855.04%
2020A-$3.86207.14%
2019A-$1.26-19.81%
2018A-$1.57

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Natera
NTRA
A-$3.20-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
A-$7.19 49.75%๐Ÿ‡บ๐Ÿ‡ธ USA